MAIDA ANTHONY E III 4
4 · SPECTRUM PHARMACEUTICALS INC · Filed Feb 22, 2019
Insider Transaction Report
Form 4
MAIDA ANTHONY E III
Director
Transactions
- Sale
Common Stock, $0.001 par value
2019-02-21$11.63/sh−5,500$63,965→ 32,988 total - Exercise/Conversion
Common Stock, $0.001 par value
2019-02-21$5.05/sh+5,500$27,775→ 38,488 total - Exercise/Conversion
Stock Option Exercise (Right to Buy)
2019-02-21−5,500→ 18,800 totalExercise: $5.05From: 2010-06-18Exp: 2020-04-20→ Common Stock (5,500 underlying)
Footnotes (1)
- [F1]All sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.